| scholarly article | Q13442814 |
| P356 | DOI | 10.1590/1806-9282.63.01.78 |
| P698 | PubMed publication ID | 28225881 |
| P2093 | author name string | Benedito Borges da Silva | |
| Ana Raquel Soares de Oliveira | |||
| Dilina do Nascimento Marreiro | |||
| Jennifer Beatriz Silva Morais | |||
| Juliana Soares Severo | |||
| Kyria Jayanne Clímaco Cruz | |||
| Aldenora Oliveira do Nascimento Holanda | |||
| P2860 | cites work | The lignan (+)-episesamin interferes with TNF-α-induced activation of VSMC via diminished activation of NF-ĸB, ERK1/2 and AKT and decreased activity of gelatinases | Q38952125 |
| Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. | Q39615375 | ||
| Role of collagenases in tumor cell invasion | Q40136575 | ||
| Matrix metalloproteinases and the development of cancer | Q41239245 | ||
| Chip gel electrophoresis as a tool for study of matrix metalloproteinase 9 interaction with metallothionein. | Q51550158 | ||
| Gelatinases and extracellular matrix metalloproteinase inducer are associated with cyclosporin-A-induced attenuation of periodontal degradation in rats. | Q53027850 | ||
| Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. | Q53575138 | ||
| Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters | Q24306742 | ||
| The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer | Q24682854 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Zinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity, cell migration and tube formation | Q28478040 | ||
| New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
| Methods of assessment of zinc status in humans: a systematic review | Q33440128 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis | Q33783677 | ||
| Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. | Q33843796 | ||
| ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts | Q33959544 | ||
| Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition | Q34025284 | ||
| Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9 | Q34049288 | ||
| Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion | Q34301309 | ||
| Genetics and the common cancers | Q34402123 | ||
| Exploration of the zinc finger motif in controlling activity of matrix metalloproteinases. | Q34622347 | ||
| Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland | Q34729836 | ||
| Physiology and pathophysiology of matrix metalloproteases. | Q35007715 | ||
| Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction | Q35671740 | ||
| Collagenases in cancer | Q36076488 | ||
| Zinc and cancer: implications for LIV-1 in breast cancer | Q36126413 | ||
| Matrix metalloproteinases: changing roles in tumor progression and metastasis | Q36422976 | ||
| The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells | Q36525804 | ||
| Matrix metalloproteinases at cancer tumor-host interface | Q36878166 | ||
| Vitamin C intake and breast cancer mortality in a cohort of Swedish women | Q37003394 | ||
| Mammary gland zinc metabolism: regulation and dysregulation | Q37213125 | ||
| Expression of matrix metalloproteinases in human breast cancer tissues | Q37260278 | ||
| MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors | Q37600292 | ||
| Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. | Q37774392 | ||
| Regulation of matrix metalloproteinase activity in health and disease | Q37810644 | ||
| An overview of a wide range of functions of ZnT and Zip zinc transporters in the secretory pathway | Q37889040 | ||
| Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression | Q38224605 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 78-84 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Revista da Associação Médica Brasileira | Q26842142 |
| P1476 | title | Zinc and metalloproteinases 2 and 9: What is their relation with breast cancer? | |
| P478 | volume | 63 |
| Q91722602 | An Innovative Platform Merging Elemental Analysis and Ftir Imaging for Breast Tissue Analysis |
| Q89616593 | Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells |
| Q90640079 | New Insights into the Occurrence of Matrix Metalloproteases -2 and -9 in a Cohort of Breast Cancer Patients and Proteomic Correlations |
Search more.